| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |